Dexamethasone, but not meloxicam, suppresses proliferation of bovine CD25+ CD4+ and CD25- CD4+ T cells.
T Maślanka, J J Jaroszewski
Index: Pol. J. Vet. Sci. 16(2) , 219-22, (2013)
Full Text: HTML
Abstract
Recently, we found that dexamethasone caused a depletion of CD25- CD4+ T cells, but it increased the number of CD25highCD4+ and CD25lowCD4+ T cells. We also determined meloxicam-induced increase in the number of CD25highCD4+ T cells. In view of this, and taking into consideration the latest reports indicating that meloxicam shows an anti-proliferative effect on bovine peripheral blood mononuclear cells, it was considered purposeful to determine the effect of both drugs on proliferation of bovine CD25highCD4+, CD25lowCD4+ and CD25- CD4+ T cells. Flow cytometry analysis and 5-bromo-2'-deoxyuridine incorporation assay were applied to detect the cell proliferation. It was demonstrated that dexamethasone, but not meloxicam, significantly reduced cell proliferation within all three evaluated CD4+ T cell subpopulations. Thus, the depletion of CD25- CD4+ T cells by treatment with dexamethasone can partly be the effect of the anti-proliferative action of the drug, however, dexamethasone-induced increase in the number of CD25highCD4+ and CD25IowCD4+ T cells cannot be the result of enhanced proliferation of these cells.
Related Compounds
Related Articles:
Immunomodulation by the Pseudomonas syringae HopZ type III effector family in Arabidopsis.
2014-01-01
[PLoS ONE 9(12) , e116152, (2014)]
2014-12-01
[Tissue Eng. Part A 20(23-24) , 3163-75, (2014)]
2014-01-01
[PLoS ONE 9(9) , e108055, (2014)]
2015-05-01
[J. Cell. Biochem. 116(5) , 754-66, (2015)]
2015-03-01
[J. Biochem. Mol. Toxicol. 29(3) , 99-108, (2015)]